Lv62
1880 积分 2022-06-23 加入
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
1小时前
已完结
In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery
11天前
已完结
Enhancing Gene Transfer Efficiency in Viral and Non-Viral Vectors for Therapeutic Delivery
19天前
已完结
Effective Quality Control is Crucial Throughout mRNA Product Development
19天前
已完结
Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins
19天前
已完结
Prevent and Reverse Metabolic Dysfunction-Associated Steatohepatitis and Hepatic Fibrosis via mRNA-Mediated Liver-Specific Antibody Therapy
20天前
已完结
Ionizable Cholesterol Analogs as the Fifth Component of Lipid Nanoparticles for Selective Targeting Delivery of mRNA
24天前
已完结
On the Influence of Fabrication Methods and Materials for mRNA‐LNP Production: From Size and Morphology to Internal Structure and mRNA Delivery Performance In Vitro and In Vivo
25天前
已完结
Overview on LNP-mRNA encapsulation unit operation: Mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics
26天前
已完结
The design, manufacture and LNP formulation of mRNA for research use
26天前
已完结
皖公网安备34019202002308
